“We have been working with RNA for several years. They are responsive, reliable, understand the nuances of our business and help us with modeling expertise that exceeds the capabilities within our corporate organization. We value them as an ecosystem partner and as a true extension of our operating team.”
“I love the RNA team. They get healthcare and we’ve worked with the team both in valuation advisory capacities as well as on strategic projects for us as we take SmithRx to the next level. These guys get it!”
“The RNA team has been incredibly professional, very responsive to our on-going and sometimes tight turnaround valuation requests and has been an absolute pleasure to work with.”
“The RNA team helped us from inception through our IPO and beyond. They are one of the top firms that I know of at the intersection of valuation, biotech and finance. I’d recommend them for my life science venture-backed company colleagues.”
A companion to our peer-reviewed paper in JPMSA... [read more]
[Extended JPMSA article summary] The financial tools most... [read more]
Most founders and CEOs understand bad clients. A... [read more]
It’s Not Always Positive Ask a biotech CEO... [read more]
Unfortunately, this actually happened. I. The Worldview Before... [read more]
Why Biotech Executives and Investors Should Understand the... [read more]
Data-Driven Narrative for Capital Formation in Life Sciences... [read more]
Since 2015, RNA Advisors has provided valuation, transactional... [read more]
RNA Advisors, LLC, a leading valuation and strategic... [read more]
Enter your email address below to receive updates from RNA Advisors.
